Latest News from: Perelman School of Medicine at the University of Pennsylvania

Add to Favorites Subscribe Share
Go to Advanced Search

Showing results

110 of 1944
Embargo will expire:
10-Dec-2018 2:00 PM EST
Released to reporters:
7-Dec-2018 1:05 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2018 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 705033

Penn Medicine Plastic Surgeons Perform World’s First Robotic Bilateral Breast Reconstruction

Perelman School of Medicine at the University of Pennsylvania

A team of surgeons from the Perelman School of Medicine at the University of Pennsylvania are the first in the world to use a surgical robot to assist with a bilateral free flap breast reconstruction, allowing patients to recover and be discharged more quickly and without the use of addictive narcotic painkillers.

Released:
6-Dec-2018 11:05 AM EST
jasin.jpg

Article ID: 704861

Penn’s Basser Center for BRCA Chooses Memorial Sloan Kettering, Cornell University Researcher Maria Jasin for 2018 Basser Global Prize

Perelman School of Medicine at the University of Pennsylvania

The Basser Center for BRCA at Penn Medicine’s Abramson Cancer Center, the world’s first comprehensive center aimed at advancing research, treatment, and prevention of BRCA-related cancers, has announced Maria Jasin, PhD, as the recipient of the sixth annual Basser Global Prize. Jasin is a member of the Developmental Biology Program at Memorial Sloan Kettering Cancer Center and a professor at the Weill Graduate School of Medical Sciences at Cornell University.

Released:
4-Dec-2018 11:05 AM EST
  • Embargo expired:
    1-Dec-2018 12:00 PM EST

Article ID: 704664

Global Trial Shows CAR T Therapy Can Lead to Durable Remissions in Non-Hodgkin’s Lymphoma

Perelman School of Medicine at the University of Pennsylvania

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).

Released:
30-Nov-2018 8:30 AM EST
AML.jpg

Article ID: 704576

FDA Approves New Targeted Drug for Leukemia Tested at University of Pennsylvania

Perelman School of Medicine at the University of Pennsylvania

The U.S. Food and Drug Administration (FDA) has approved the first ever inhibitor drug specifically approved for treating patients with relapsed or refractory acute myeloid leukemia (AML) with a mutation in the Fms-like tyrosine kinase 3 (FLT3) gene.

Released:
28-Nov-2018 3:00 PM EST
  • Embargo expired:
    28-Nov-2018 11:00 AM EST

Article ID: 704344

Researchers Discover Why Some Parts of the Body Have Hair and Others Don’t

Perelman School of Medicine at the University of Pennsylvania

Why do humans have hair on our arms and legs but not on the palms of our hands and the soles of our feet? It’s a fundamental question in human evolution that researchers at the Perelman School of Medicine at the University of Pennsylvania say they’ve found clues to in a new study.

Released:
26-Nov-2018 9:00 AM EST

Article ID: 704454

Breaking Through The Medical Fake News Bubble

Perelman School of Medicine at the University of Pennsylvania

To combat "fake news" that undermines health information, a pair of health scientists explain what to think about when trying to break through people's spheres of influence when it comes to research.

Released:
27-Nov-2018 10:55 AM EST
CARTCellBag.jpg

Article ID: 704345

CAR T Studies Highlight Abramson Cancer Center Research at ASH Annual Meeting

Perelman School of Medicine at the University of Pennsylvania

Penn researchers will present findings at the 60th American Society of Hematology Annual Meeting and Exposition in San Diego, including studies that evaluate CAR T combinations, how the timing of CAR T therapy may impact its effectiveness, and which patients who currently aren’t eligible for CAR T therapy should have greater access.

Released:
26-Nov-2018 9:00 AM EST
  • Embargo expired:
    21-Nov-2018 2:15 PM EST

Article ID: 704294

Treating Spinal Pain with Replacement Discs Made of “Engineered Living Tissue” Moves Closer to Reality

Perelman School of Medicine at the University of Pennsylvania

For the first time, bioengineered spinal discs were successfully implanted and provided long-term function in the largest animal model ever evaluated for tissue-engineered disc replacement. A new Penn Medicine study published in Science Translational Medicine provides compelling translational evidence that the cells of patients suffering from neck and back pain could be used to build a new spinal disc in the lab to replace a deteriorated one. The study, which was performed using goats, was conducted by a multidisciplinary team in the University of Pennsylvania’s Perelman School of Medicine, School of Engineering and Applied Science, and School of Veterinary Medicine.

Released:
20-Nov-2018 4:00 PM EST
PCAM_South_Pavilion.jpg
  • Embargo expired:
    20-Nov-2018 12:05 AM EST

Article ID: 704184

Abramson Cancer Center Joins National Comprehensive Cancer Network

Perelman School of Medicine at the University of Pennsylvania

The Abramson Cancer Center at the University of Pennsylvania announced today that it is joining the National Comprehensive Cancer Network® as its 28th member institution.

Released:
19-Nov-2018 10:05 AM EST

Showing results

110 of 1944

Chat now!